FDA-filed SPL labeling · retrieved through openFDA

Betamethasone

Betamethasone is a topical corticosteroid used to relieve inflammation and itching caused by skin conditions, including corticosteroid-responsive dermatoses and plaque psoriasis.

Brand names LuxiqBetavetSernivoDel-BetaDiprolene
Drug class Corticosteroid Hormone Receptor Agonists
Rx Forms 3 Routes Topical · Cutaneous
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 83 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveApr 22, 2026
Clinical labels in scope 83
AvailabilityRx
Earliest approval/marketing year 1961
FDA-listed product records 244
Boxed warningNone found in compared labels
How we combine label and product data →
No current FDA shortage listed · checked Sep 22, 2026
Other forms & routes:
Betamethasone at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Betamethasone topical products are effective treatments for inflammatory skin conditions and plaque psoriasis, but they should be used on the smallest area of skin for the shortest time needed. Follow your prescriber's guidance on which formulation to use and for how long, since overuse — especially of high-potency versions — can affect your body's hormone system and cause skin thinning. Always keep it away from your eyes and off sensitive areas like the face or groin unless your doctor tells you otherwise.

📖 Betamethasone: Patient Information Guide

A plain-language walkthrough of Betamethasone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Betamethasone is a topical corticosteroid available in several formulations and brands, each with specific approved uses.

  • Betamethasone Dipropionate creams, ointments, and gels (including Diprolene Ointment) treat itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
  • Betamethasone Valerate cream and ointment treat itching and inflammation from corticosteroid-responsive dermatoses
  • Betamethasone valerate foam is specifically approved for corticosteroid-responsive dermatoses of the scalp
  • Betamethasone dipropionate spray and Sernivo Spray are specifically approved for mild to moderate plaque psoriasis in adults 18 years and older
⚙️How it works

Betamethasone is a corticosteroid — a type of steroid that works within skin cells to dial down inflammation. It influences immune signaling, reduces inflammatory chemicals, and calms the overactive immune response that causes the redness, swelling, and itching seen in skin conditions. The exact way it helps plaque psoriasis specifically is not fully known, but its anti-inflammatory action is central to its effect.

💊How it's taken

The right way to use betamethasone depends on which product you have. Creams and ointments are generally applied as a thin film once or twice a day. Betamethasone Valerate lotion is applied as a few drops massaged in lightly, typically twice a day. The foam for scalp conditions is dispensed onto a cool surface and massaged in twice daily. Sprays (betamethasone dipropionate spray and Sernivo) are shaken before use and applied twice daily for up to 4 weeks.

  • Discontinue use when the skin condition is controlled — don't use longer than needed
  • If there's no improvement after 2 weeks (or 4 weeks for sprays), contact your prescriber
  • Do not use with tight bandages or wraps (occlusive dressings) unless your doctor says so
  • For all forms: avoid the face, groin, and underarms unless directed by your doctor
🤒Side effects — in detail

The most common side effects are at the spot where you apply the medication. These include:

  • Itching, burning, or stinging at the application site
  • Pain at the application site
  • Skin thinning (atrophy)
  • Stretch marks (striae)
  • Folliculitis (inflamed hair follicles)
  • Skin irritation, dryness, or discoloration
  • Acne-like breakouts
  • Hypopigmentation (lightening of the skin)

More serious reactions — including signs of hormone suppression (unusual fatigue or weakness), eye problems like cataracts or glaucoma, or signs of allergic contact dermatitis — require prompt medical attention.

⚠️Warnings & precautions
  • HPA axis suppression (adrenal suppression): Using too much betamethasone or applying it over large areas of skin for too long can interfere with your body's ability to produce cortisol — a hormone you need for stress response. High-potency formulations, broken skin, liver problems, and use under dressings increase this risk. Children are especially vulnerable.
  • Eye risks: Getting this medication near your eyes — or using it around the eye area — can raise the risk of cataracts and glaucoma over time. Always avoid eye contact and report any new vision changes.
  • Skin thinning and other skin changes: Long-term use can cause the skin to become thin, develop stretch marks, or show changes in color. Do not use on areas that already have skin thinning.
  • Allergic contact dermatitis: If your skin condition stops improving or gets worse, it could be an allergic reaction to the product itself. Talk to your doctor if this happens.
  • Pregnancy: Using large amounts of potent topical corticosteroids during pregnancy has been linked to a risk of low birth weight. Use the smallest effective amount for the shortest time.
🔀What it interacts with

The FDA labels for betamethasone topical products do not describe specific drug-drug or drug-food interactions. Always tell your prescriber and pharmacist about all medications and supplements you take.

  • Using betamethasone under tight bandages or occlusive dressings increases how much is absorbed through the skin — this is not a drug interaction but raises the risk of systemic side effects

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Do not use if you are allergic to betamethasone, other corticosteroids, or any ingredient in the specific product
  • Tell your doctor if you are pregnant — heavy or prolonged use of potent topical corticosteroids may increase the risk of low birth weight in the baby
  • If you are breastfeeding, avoid applying to the nipple or areola; discuss benefits and risks with your doctor
  • Most betamethasone topical products are not recommended for children under 13 years of age (some under 12) due to a higher risk of adrenal suppression
  • Patients with liver failure may absorb more through the skin and should use these products with extra care
  • Do not apply to areas where the skin is already thin (atrophy is present)
  • Avoid the face, groin, underarms, and skin folds unless your prescriber specifically instructs you to use it there
📡Pharmacodynamics — effects in the body

When applied to the skin, betamethasone works as a vasoconstrictor — meaning it narrows blood vessels — which is one marker of its anti-inflammatory potency. Betamethasone dipropionate spray, for example, is considered mid-range in potency compared to other topical corticosteroids based on these vasoconstriction studies. Used over large areas of skin, it can measurably affect the body's cortisol levels, reflecting absorption beyond just the skin surface.

🔬Pharmacokinetics — how your body processes it

How much betamethasone gets absorbed through the skin depends on several factors: the specific vehicle (cream, ointment, spray, etc.), whether the skin barrier is intact, and whether occlusive dressings are used. Inflamed or damaged skin absorbs more of the medication than healthy, intact skin. In studies of betamethasone dipropionate spray, most subjects had no measurable drug levels in the bloodstream, suggesting minimal systemic absorption under typical conditions.

📦How to store it

Store at 20° to 25°C (68° to 77°F) .

📄 Written from Betamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Betamethasone — the kind of thing our pharmacy team would talk through with you at the counter.

What skin conditions does betamethasone treat?
Betamethasone is a steroid cream (or ointment, gel, spray, or foam) that treats skin conditions where inflammation is the problem — things like eczema, psoriasis, and other conditions that cause redness and itching. The spray forms, like Sernivo, are specifically approved for mild to moderate plaque psoriasis. The foam version is made just for the scalp. Your doctor picked the specific formulation based on your condition and where it's located on your body.
How do I apply it correctly?
For creams and ointments, apply a thin layer to the affected area once or twice a day — less is more with these products. For the spray (like Sernivo), shake it well first, spray onto the affected skin, and rub it in gently. For the scalp foam, dispense it onto a cool surface first (not your warm hands) and then massage it into your scalp. Always wash your hands after applying, keep it away from your eyes, and avoid using it on your face, groin, or underarms unless your doctor specifically tells you to.
How long can I use betamethasone?
That depends on the product. Most creams and ointments should be used for no more than 2 consecutive weeks. The spray forms — including Sernivo — are approved for up to 4 weeks. You should stop using it as soon as your skin clears up, even if that's sooner. If things aren't improving after 2 to 4 weeks, reach out to your doctor rather than continuing on your own.
What side effects should I watch out for?
The most common issues are mild ones right where you apply it — itching, burning, stinging, or skin thinning. These are usually manageable. The more serious thing to know is that using too much over a large area for a long time can affect your body's hormone levels (specifically cortisol). If you feel unusually tired or weak, especially after stopping the medication, let your doctor know. Also, if you accidentally get it near your eyes regularly, it can increase the risk of cataracts or glaucoma over time — so keep it away from your eyes.
Is it safe to use if I'm pregnant or breastfeeding?
You should talk to your doctor before using this if you're pregnant or breastfeeding. Using large amounts of potent topical corticosteroids during pregnancy has been linked to a risk of low birth weight babies. If your doctor decides it's needed, use the smallest amount on the smallest area for the shortest time possible. If you're breastfeeding, don't apply it to your nipple or areola area so your baby isn't directly exposed through skin contact.
Can I cover the skin with a bandage after applying betamethasone?
Generally, no — you should not cover the treated area with a tight bandage or wrap unless your doctor specifically tells you to. Covering the skin (called occlusion) significantly increases how much medication is absorbed into your body, which raises the risk of side effects like hormone suppression. This applies to all the betamethasone products. Loose clothing is fine; it's air-tight wraps and bandages you want to avoid.
Is Betamethasone available over the counter?
Betamethasone is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Betamethasone first available?
Betamethasone has been available in the United States since at least 1961, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Betamethasone?
Betamethasone is supplied by 60 manufacturers listed in the FDA NDC Directory, including A-S Medication Solutions, Preferred Pharmaceuticals, Inc., NuCare Pharmaceuticals,Inc..

💬 Answers drafted from Betamethasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Betamethasone comes

Betamethasone is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Topical cream, ointment or gel

On the skin
Brands Diprolene
How this form is used
What it may be used for
  • Betamethasone Dipropionate cream and ointment are used to relieve itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
  • Betamethasone Valerate cream and ointment are used to relieve itching and inflammation from corticosteroid-responsive dermatoses
  • Diprolene Ointment is used to relieve itching and inflammation from corticosteroid-responsive dermatoses in patients 13 years and older
Important instructions
  • Betamethasone Dipropionate and Diprolene Ointment: apply a thin film to the affected area once or twice daily; do not exceed 50 g per week
  • Betamethasone Valerate cream or ointment: apply a thin film one to three times a day; once or twice daily is often effective
  • Diprolene Ointment: avoid use on the face, groin, or underarms, and avoid contact with eyes; wash hands after each application
  • All creams and ointments: do not use with occlusive dressings unless directed by a physician, and discontinue when the condition is controlled
Available strengths 5 strengths
182 FDA-listed product records

Inhaler

On the skin
Brands Luxiq
How this form is used
What it may be used for
  • Betamethasone valerate foam is used to relieve itching and inflammation from corticosteroid-responsive dermatoses of the scalp
Important instructions
  • Betamethasone valerate foam: invert the can to dispense a small amount onto a cool surface — do not dispense directly onto hands
  • Betamethasone valerate foam: pick up small amounts with fingers and gently massage into the affected scalp area until it disappears
  • Betamethasone valerate foam: apply twice daily, once in the morning and once at night
  • Betamethasone valerate foam: do not use with occlusive dressings unless directed by a physician
Available strengths 1 strength
11 FDA-listed product records

Topical spray

On the skin
Brands Sernivo
How this form is used
What it may be used for
  • Betamethasone dipropionate spray is indicated for mild to moderate plaque psoriasis in adults 18 years and older
  • Sernivo Spray is indicated for mild to moderate plaque psoriasis in adults 18 years and older
Important instructions
  • Betamethasone dipropionate spray and Sernivo Spray: shake well before use, apply to affected areas twice daily, and rub in gently
  • Betamethasone dipropionate spray and Sernivo Spray: use for up to 4 weeks only — treatment beyond 4 weeks is not recommended
  • Betamethasone dipropionate spray and Sernivo Spray: avoid use on the face, scalp, underarms, groin, or other skin folds
  • Betamethasone dipropionate spray and Sernivo Spray: do not bandage, cover, or wrap the treated area unless directed by a physician
Available strengths 1 strength
7 FDA-listed product records

📊 Betamethasone across the U.S. market

How Betamethasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

3
Dose forms
60
Manufacturers
5
Brand names
244
FDA-listed product records
1961
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (44) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

A-S Medication Solutions14%
Preferred Pharmaceuticals, Inc.6%
NuCare Pharmaceuticals,Inc.6%
Bryant Ranch Prepack5%
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC5%
Padagis Israel Pharmaceuticals Ltd4%
Other makers59%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Betamethasone is used

A general measure of how commonly Betamethasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Betamethasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

403,381
Medicaid prescriptions filled (Q1–Q4 2025)
$11.3M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Betamethasone prescribed? Of the 1,596 medications we measure, Betamethasone ranks #288 by Medicaid prescriptions — more than 82% of them.

Where Betamethasone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Betamethasone product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 0.5 mg/mL topical cream is the most-dispensed Betamethasone product — about 26% of these Medicaid prescriptions.

betamethasone 0.5 MG/ML Topical Cream Most dispensed

104,669 Medicaid prescriptions (Q1–Q4 2025) 26% of Betamethasone prescriptions shown $3.2M gross reimbursement (before rebates) ≈ $30 per prescription (gross)

Summed across the 12 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 238920

betamethasone 1 MG/ML Topical Cream

92,311 Medicaid prescriptions (Q1–Q4 2025) 23% of Betamethasone prescriptions shown $2.2M gross reimbursement (before rebates) ≈ $24 per prescription (gross)

Summed across the 6 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197407

betamethasone 0.0005 MG/MG Topical Ointment

53,062 Medicaid prescriptions (Q1–Q4 2025) 13% of Betamethasone prescriptions shown $1.7M gross reimbursement (before rebates) ≈ $33 per prescription (gross)

Summed across the 10 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197405

betamethasone 0.001 MG/MG Topical Ointment

45,581 Medicaid prescriptions (Q1–Q4 2025) 11% of Betamethasone prescriptions shown $1.2M gross reimbursement (before rebates) ≈ $27 per prescription (gross)

Summed across the 4 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197409

Augmented betamethasone 0.5 MG/ML Topical Cream

41,072 Medicaid prescriptions (Q1–Q4 2025) 10% of Betamethasone prescriptions shown $527,082 gross reimbursement (before rebates) ≈ $13 per prescription (gross)

Summed across the 4 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848176

betamethasone 0.5 MG/ML Topical Lotion

30,159 Medicaid prescriptions (Q1–Q4 2025) 7% of Betamethasone prescriptions shown $790,166 gross reimbursement (before rebates) ≈ $26 per prescription (gross)

Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 240209

Augmented betamethasone 0.0005 MG/MG Topical Ointment

20,361 Medicaid prescriptions (Q1–Q4 2025) 5% of Betamethasone prescriptions shown $948,216 gross reimbursement (before rebates) ≈ $47 per prescription (gross)

Summed across the 10 of 25 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848180

betamethasone 1 MG/ML Topical Lotion

11,914 Medicaid prescriptions (Q1–Q4 2025) 3% of Betamethasone prescriptions shown $522,603 gross reimbursement (before rebates) ≈ $44 per prescription (gross)

Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197408

Augmented betamethasone 0.5 MG/ML Topical Lotion

3,460 Medicaid prescriptions (Q1–Q4 2025) <1% of Betamethasone prescriptions shown $156,723 gross reimbursement (before rebates) ≈ $45 per prescription (gross)

Summed across the 4 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848178

betamethasone valerate 1.2 MG/ML Topical Foam

627 Medicaid prescriptions (Q1–Q4 2025) <1% of Betamethasone prescriptions shown $51,084 gross reimbursement (before rebates) ≈ $81 per prescription (gross)

Summed across the 6 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1244634

Augmented betamethasone 0.0005 MG/MG Topical Gel

165 Medicaid prescriptions (Q1–Q4 2025) <1% of Betamethasone prescriptions shown $15,840 gross reimbursement (before rebates) ≈ $96 per prescription (gross)

Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848208

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Betamethasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 62 of 171 listed Betamethasone NDCs with Medicaid activity.

🔍 Compare Betamethasone products

A representative set of FDA-listed product records for Betamethasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 244 products — FDA National Drug Code Directory. See every product, package size and price: browse all 244 Betamethasone NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Betamethasone RxCUI 1514 13 dose forms · 22 strengths
  1. Dose form (SCDF) Disintegrating Oral Tablet RxCUI 379265 No current FDA listing
    Clinical drug / strength (SCD) 0.5 MG RxCUI 105389
  2. Dose form (SCDF) Injectable Solution RxCUI 371049 No current FDA listing
    Clinical drug / strength (SCD) 4 MG/ML RxCUI 308718
  3. Dose form (SCDF) Injectable Suspension RxCUI 378340 No current FDA listing
    Clinical drug / strength (SCD) 6 MG/ML RxCUI 1660745
  4. Dose form (SCDF) Ophthalmic Ointment RxCUI 376457 No current FDA listing
    Clinical drug / strength (SCD) 0.001 MG/MG RxCUI 249596
  5. Dose form (SCDF) Oral Solution RxCUI 371053 No current FDA listing
    Clinical drug / strength (SCD) 0.12 MG/ML RxCUI 670084
  6. Dose form (SCDF) Oral Tablet RxCUI 371056 No current FDA listing
    Clinical drug / strength (SCD) 0.5 MG RxCUI 245258 0.6 MG RxCUI 308709
  7. Dose form (SCDF) Topical Foam RxCUI 384499 In current FDA listings
    Clinical drug / strength (SCD) valerate 1.2 MG/ML RxCUI 1244634
  8. Dose form (SCDF) Topical Gel RxCUI 377967 In current FDA listings
    Clinical drug / strength (SCD) Augmented betamethasone 0.0005 MG/MG RxCUI 848208 0.0005 MG/MG RxCUI 240571
  9. Dose form (SCDF) Topical Solution RxCUI 371057 No current FDA listing
    Clinical drug / strength (SCD) 1 MG/ML RxCUI 250861
  10. Dose form (SCDF) Topical Spray RxCUI 377311 In current FDA listings
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 1738536

Look up RxCUI 1514 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Luxiq Betavet Sernivo Del-Beta Diprolene

🏭 Manufacturers & labelers

A-S Medication Solutions 32 Preferred Pharmaceuticals, Inc. 13 NuCare Pharmaceuticals,Inc. 13 Bryant Ranch Prepack 12 E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 11 Padagis Israel Pharmaceuticals Ltd 10 Actavis Pharma, Inc. 9 E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 9 Remedyrepack Inc. 8 Taro Pharmaceuticals U.S.A., Inc. 8 RPK Pharmaceuticals, Inc. 7 Cosette Pharmaceuticals, Inc. 7 Sun Pharmaceutical Industries, Inc. 7 Proficient Rx LP 6 Symbiotec Pharmalab Limited 5 Preferred Pharmaceuticals Inc. 5 Symbiotica Speciality Ingredients Sdn.bhd 4 Sicor S.r.l. 4 Newchem Spa 4 Zydus Lifesciences Limited 3 Professional Compounding Centers of America dba PCCA 3 Primus Pharmaceuticals, Inc. 3 Medisca Inc. 3 Northstar Rx LLC. 3

…and 16 more on the FDA NDC directory.

RxNorm drug class

Betamethasone belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids acting locally, Corticosteroids, Corticosteroids, potent (group III)
How it works Corticosteroid Hormone Receptor Agonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Apr 22, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Betamethasone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Betamethasone after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
83
NDC products indexed
244
Distinct labelers/manufacturers represented
60
Linked representative label
Primus Pharmaceuticals, Inc.
Linked label effective
Apr 22, 2026
Composite sections available
22
Linked SPL Set ID
b1b3d1b0-da9b-11eb-ad76-0800200c9a66
Linked SPL Document ID
8310ee9a-2de4-4246-a1ed-6fd23d041962
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 83 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Primus Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.